Leap Therapeutics, INC. (CYPH) — 10-Q Filings

10-Q Filings (5)

• Leap Therapeutics' Cash Dwindles Amidst Restructuring, Going Concern Warning — Aug 14, 2025 Risk: high
  LEAP THERAPEUTICS, INC. (CYPH) reported a net loss of $16.643 million for the three months ended June 30, 2025, an improvement from the $20.128 million net loss
• Leap Therapeutics Q1 2025 Financial Update — May 13, 2025 Risk: medium
  Leap Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $41.4 million and total liabilities of $3.8 mi
• Leap Therapeutics Q3 2024 Update: Assets & Liabilities Detailed — Nov 13, 2024 Risk: medium
  Leap Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $25.6 million and total liabilities of $38
• Leap Therapeutics Reports Q2 2024 Results — Aug 12, 2024 Risk: high
  Leap Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $25.57 million and total liabilities of $4.20 m
• LEAP THERAPEUTICS, INC. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
  LEAP THERAPEUTICS, INC. (CYPH) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. LEAP THERAPEUTICS, INC. filed a 10-Q for the period ending March 31

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX